Login

Simone Veglioni discusses VANTEA SMART while EGOMNIA S.p.A. details strengths and projects in an online IPO talk. 00:10:00

Share On Facebook Share On Twitter

Simone Veglioni ceo of Vantea SMART S.p.A

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Examining the Cost Dynamics in Higher Education: The Rise of Online Program Managers (OPMs)|John Katzman,Founder of 2U
00:10:00
Patrick Stokes (Gibson Dunn) Discusses the Importance of the Foreign Extortion Prevention Act for Companies | Barbara L. Becker - Chair & Managing Partner of gibson dunn
00:10:00
Gas Recovery Projects: Reducing Carbon Footprint and Stimulating Local Economies | Julien Moulin, CEO, La Francaise de l Energie SA.
00:10:00
Eric led investments in enterprise software companies such as Confluent and Amplitude, both of which IPO'ed in 2021. 
00:10:00
invest in should be making a positive difference in the world|Matt Harris, Partner, Bain Capital Ventures
00:10:00
Finance is defined as any financial exchange whereby a non financial institution offers financial services|Sarah Hinkfuss,Partner,Bain Capital Ventures
00:10:00
Kohl's Faces Dire Straits Amid Struggling Sales Process and Takeover Bids
00:10:00
Fernando González Olivieri Addresses December 2023 Graduates at Tecnológico de Monterrey | Fernando Angel Angel Gonzalez Olivieri - CEO of Cemex
00:10:00
Finding the Best Investment Strategy for You | Adam Taylor, CEO, Taylor Financial.
00:10:00
Rincon Resources CEO Discusses Exploration Plans and Prospects for 2021 on Assay TV
00:10:00
According to the CEO, Brady Plc's half-year results reflect solid sales momentum. | Nick King, CEO, Brady PLCBRY:LSE
00:10:00
Presentation on Namibian Critical Metals Portfolio

© 2026 Nehu